Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Bullboard Posts
Comment by Amateur123on Mar 22, 2019 2:46pm
98 Views
Post# 29524503

RE:Warrants tell us this going well over 2 by end year

RE:Warrants tell us this going well over 2 by end year Given that the warrants currently trade at $0.07 per it means that the people who are purchasing believe that the stock will trade above $2.37 before Jan 30 2020. While I do count myself among the people who believe that this stock will trade above 2.37 by the expiry date it is only fair to clearly state that there is still significant risk associted with this belief. Any number of adverse things could happen to slow stock growth including but not limited to:
  1. The Delivera deal being delayed or failing
  2. Expansion being delayed
  3. A change in government introducing uncertainty to the cannabis market
While and educated one, it is still at best a guess that the stock will reach these levels. 
Bullboard Posts